Nadecnemab

Product Description: Nadecnemab is an IgG4κ antibody targeting to GFRA3, glial cell derived neurotrophic factor family receptor alpha 3. Nadecnemab can be used for research of osteoarthritis of the knee/pain[1].

Applications: COVID-19-immunoregulation

Formula: N/A

References: [1]Nadecnemab. Drugbank.

Molecular Weight: N/A

Compound Purity: 95.00

Research Area: Inflammation/Immunology

Solubility: 10 mM in DMSO

Target: TGF-β Receptor

• SKU: MEXHY-P99748-1
• Manufacturer: MedChemExpress
• Manufacturer SKU: HY-P99748-1
• Package Unit: 1 mg
• Quantity Unit: STK
• Conjugate: Unconjugated